| 000 -LEADER |
|---|
| fixed length control field |
01374cam a2200325 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20150716091019.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
021125s xx 000 0 eng |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
1522-3191; |
| 050 #0 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
AC1.S5 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
050 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Godwin, Mike. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Prescription Panic. / |
| Statement of responsibility, etc. |
Mike Godwin. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Name of publisher, distributor, etc. |
Reason, |
| Date of publication, distribution, etc. |
2002. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
SIRS Enduring Issues 2003. |
| Number of part/section of a work |
Article 64. |
| Name of part/section of a work |
Business, |
| International Standard Serial Number |
1522-3191; |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Articles Contained in SIRS Enduring Issues 2003. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Originally Published: Prescription Panic, Feb. 2002; pp. 32-37. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Before September 11 [2001], U.S. policy toward pharmaceutical patents was clear: The interests of the patent holder came first. However, the anthrax scare that surfaced in October has managed to shake that policy to its roots." (REASON) This article discusses how a public health scare can change policies related to pharmaceutical patents. |
| 599 ## - |
|---|
| -- |
Records created from non-MARC resource. |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Bayer Corporation. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Anthrax. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Ciprofloxacin. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Law and legislation. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Intellectual property. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Patents. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical industry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Prescription drugs. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Public health. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SIRS Publishing, Inc. |
| Title of a work |
SIRS Enduring Issues 2003. |
| Name of part/section of a work |
Business., |
| International Standard Serial Number |
1522-3191. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
|
